Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00399061
Status:
COMPLETED
Last Update Posted:
2008-09-25
First Post:
2006-11-09
Brief Title:
Efficacy of Optive Versus Systane Concomitant With Restasis Cyclosporine A for the Treatment of Dry Eye Symptoms
Sponsor:
Innovative Medical
Organization:
Innovative Medical
Study Overview
Official Title:
Efficacy of Optive Versus Systane Concomitant With Restasis Cyclosporine A for the Treatment of Dry Eye Symptoms
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None